Intraperitoneal injection but not oral administration of ellagic acid: a novel immunomodulator via targeting casein kinase 2 signaling pathway

Immunosuppressants currently approved for the treatment of autoimmune diseases and organ transplant rejection present diverse adverse effects that impair the life quality of patients. Therefore, the development of novel immunomodulators with high efficiency and low toxicity is essential. Ellagic aci...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Wenhui Qi, Bing Han, Tingting Cui, Peixin Shen, Zhuohua Zhao, Yaping Yan, Libin Wang, Xinyu Lu, Yuan Zhang, Xing Li
Format:	Artigo
Jezik:	Inglês
Izdano:	Tsinghua University Press 2025-07-01
Serija:	Food Science and Human Wellness
Teme:	ellagic acid experimental autoimmune encephalomyelitis neuromyelitis optica organ transplantation casein kinase ⅱ t helper cell 17
Online dostop:	https://www.sciopen.com/article/10.26599/FSHW.2024.9250157
Oznake:	Označite Brez oznak, prvi označite!